i am sometimes critical of pumpers who promise much with little evidence but you excel in threatening much with no argument at all. you can't even spell your own avatar name; you offer nothing in support of your doomsday prediction. you are not just wrong, you are so wrong as to be laughable.
At $3PPS, the Company has a market cap of $175 million. Thus, you can almost buy the Company for free with its OWN $143MM in cash and equivalents.
PLUS, you then get an "infinite" return on your zero money down on the ongoing existing ANNUAL $180MM revenue stream, and receive for ZERO (ii) ALL the Company's rights to the 3 existing FDA approved drugs (i.e. Fusilev, Folotyn and Zevalin), (iii) rights to the 3 drugs subject to the upcoming FDA filings for Belinostat, Apaziquone etc. AND (iv) get Renazorb, all the SP drugs and the entire rest of the Oncology and Hematology pipeline.... for ZERO. Good luck with that!
Just for kicks, name one other BioTech with a $400 MM market cap with $180 MM in revenues which has any kind of pipeline whatsoever.